Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10685)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2019 (publication date) through Jul 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cao J, Kong FH, Liu X, Wang XB. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2019; 25(27): 3649-3663 [PMID: 31367163 DOI: 10.3748/wjg.v25.i27.3649] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6190/full/v25/i27/3649.htm |
| Number | Citing Articles |
| 1 |
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic, Dragan Masulovic. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine 2022; 12(2): 149 doi: 10.3390/jpm12020149
|
| 2 |
Rachel M. Golonka, Matam Vijay-Kumar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 171 doi: 10.1016/bs.acr.2020.10.004
|
| 3 |
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos, Timothy M. Pawlik. The Immunology of Hepatocellular Carcinoma. Vaccines 2021; 9(10): 1184 doi: 10.3390/vaccines9101184
|
| 4 |
Yuting Qiu, Haobo Li, Jiaheng Xie, Xinwei Qiao, Jing Wu. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis. International Journal of General Medicine 2021; : 7235 doi: 10.2147/IJGM.S333904
|
| 5 |
Fanhua Kong, Kunpeng Wang, Liezhi Wang. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00595-x
|
| 6 |
Xiao-Wan Bo, Li-Ping Sun, Song-Yuan Yu, Hui-Xiong Xu. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions. World Journal of Gastrointestinal Oncology 2021; 13(10): 1397-1411 doi: 10.4251/wjgo.v13.i10.1397
|
| 7 |
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinoma. Cancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
|
| 8 |
Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Si-Yu Tan, Dong-Xu Wang, Tao Li. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers 2022; 14(16): 4036 doi: 10.3390/cancers14164036
|
| 9 |
Marine Valery, Baptiste Cervantes, Ramy Samaha, Maximiliano Gelli, Cristina Smolenschi, Alina Fuerea, Lambros Tselikas, Caroline Klotz-Prieux, Antoine Hollebecque, Valérie Boige, Michel Ducreux. Immunotherapy and Hepatocellular Cancer: Where Are We Now?. Cancers 2022; 14(18): 4523 doi: 10.3390/cancers14184523
|
| 10 |
Ai-Yu Nie, Zhong-Hui Xiao, Jia-Li Deng, Na Li, Li-Yuan Hao, Sheng-Hao Li, Xiao-Yu Hu. Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(2): 98556 doi: 10.4251/wjgo.v17.i2.98556
|
| 11 |
Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2020; 69(5): 825 doi: 10.1007/s00262-020-02486-y
|
| 12 |
Disha D. Shah, Bhavarth P. Dave, Parv A. Patel, Mehul R. Chorawala, Vishvas N. Patel, Palak A. Shah, Manish P. Patel. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Medical Oncology 2023; 40(2) doi: 10.1007/s12032-023-01948-4
|
| 13 |
Tong Wu, Linzhi Zhang, Zhen Zeng, Tao Yan, Jiamin Cheng, Xiaojie Miao, Yinying Lu. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases. OncoTargets and Therapy 2021; : 5447 doi: 10.2147/OTT.S333604
|
| 14 |
He Huang, Shilei Xu, Aidong Chen, Fen Li, Jiezhong Wu, Xusheng Tu, Kunpeng Hu, Makoto Endo. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients. Analytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6697407
|
| 15 |
Juwita N. Rahmat, Jiayi Liu, Taili Chen, ZhiHong Li, Yong Zhang. Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation. Chemical Society Reviews 2024; 53(11): 5862 doi: 10.1039/D3CS00602F
|
| 16 |
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, Ludovica Ceci, Leonardo Baiocchi, Lindsey Kennedy, Sanjukta Chakraborty, Shannon Glaser, Heather Francis, Gianfranco Alpini, Keisaku Sato. The Functional Roles of Immune Cells in Primary Liver Cancer. The American Journal of Pathology 2022; 192(6): 826 doi: 10.1016/j.ajpath.2022.02.004
|
| 17 |
Yuyin Le, Hui Kong, Xu Gao, Jinxiu Zhu, Gang Chen. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/8371885
|
| 18 |
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
|
| 19 |
Ying Liu, Song Liu, Guang Sheng Zhao, Xiang Li, Fei Gao, Zhi Zhong Ren, Jie Bian, Jian Lin Wu, Yue Wei Zhang. Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.889312
|
| 20 |
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
|
| 21 |
Kuijie Liu, Zhenyu Cao, Siqi Huang, Fanhua Kong. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04244-w
|
| 22 |
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. International Journal of Molecular Sciences 2022; 23(7): 3778 doi: 10.3390/ijms23073778
|
| 23 |
Romain Donne, Amaia Lujambio. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 2023; 77(5): 1773 doi: 10.1002/hep.32740
|
| 24 |
Xiongpei Huang, Zecheng Qiu, Liusheng Li, Bin Chen, Peiyuan Huang. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Aging 2021; 13(16): 20698 doi: 10.18632/aging.203456
|
| 25 |
Shuo Wang, Xiaoli Wang, Xinna Zhou, Herbert Kim Lyerly, Michael A. Morse, Jun Ren. DC-CIK as a widely applicable cancer immunotherapy. Expert Opinion on Biological Therapy 2020; 20(6): 601 doi: 10.1080/14712598.2020.1728250
|
| 26 |
Marcelo M. Rodríguez, Agostina Onorato, María José Cantero, Luciana Domínguez, Juan Bayo, Esteban Fiore, Mariana García, Catalina Atorrasagasti, Ali Canbay, Mariana Malvicini, Guillermo D. Mazzolini. 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85491-0
|
| 27 |
Harriet Roddy, Tim Meyer, Claire Roddie. Novel Cellular Therapies for Hepatocellular Carcinoma. Cancers 2022; 14(3): 504 doi: 10.3390/cancers14030504
|
| 28 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1): 437 doi: 10.3390/ijms24010437
|
| 29 |
Sixun Zhong, Yan Zhang, Xiaomin Lu, Vafa Meftahpour. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer. Journal of Interferon & Cytokine Research 2024; 44(3): 99 doi: 10.1089/jir.2023.0180
|
| 30 |
Tao Zhang, Cong Ren, Zhanyu Yang, Ning Zhang, Haowen Tang. Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1569150
|
| 31 |
Guodai Hong, Silun Xie, Zikuan Guo, Diping Zhang, Sihai Ge, Suqin Zhang, Wenbin Gao. Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case Report. OncoTargets and Therapy 2022; : 255 doi: 10.2147/OTT.S344707
|
| 32 |
Harry Cheuk Hay Lau, Joseph Jao-Yiu Sung, Jun Yu. Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2020.1869504
|
| 33 |
Haipeng Zhu, Xiaojun Liu. Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.666340
|
| 34 |
Haoyang Chen, Huihui Liu, Xiaowei Zhang, Suhua Wang, Chunxia Liu, Ke An, Ruijuan Liu, Xin Tian. Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1422033
|
| 35 |
Eleni-Myrto Trifylli, Evangelos Koustas, Nikolaos Papadopoulos, Panagiotis Sarantis, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Michalis V. Karamouzis. An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma. Life 2022; 12(5): 665 doi: 10.3390/life12050665
|
| 36 |
Dong Xie, Yang Liu, Fangbiao Xu, Zhibo Dang, Mengge Li, Qinsheng Zhang, Zhongqin Dang. Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1581098
|
| 37 |
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
|
| 38 |
Li Zhang, Jia Ding, Hui-Yan Li, Zhong-Hua Wang, Jian Wu. Immunotherapy for advanced hepatocellular carcinoma, where are we?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188441 doi: 10.1016/j.bbcan.2020.188441
|